by Andreu Prados
While for almost all of human evolution our food and water have contained large numbers of microorganisms, the industrialized human diet contains low microbial numbers. So are we ready to recommend a specific daily intake of microbes?
by GMFH Editing Team
Beyond antibiotics, a wide range of commonly used non-antibiotic drugs can affect the gut microbiome. In addition, the gut microbiome can also influence an individual’s response to drugs by affecting their efficacy and safety. What are the implications of the bidirectional interaction between non-antibiotic drugs and the gut microbiome in the clinical setting?
by Andreu Prados
Although the COVID-19 pandemic has shifted the focus of research for scientists worldwide, major breakthroughs in gut microbiome science have been made in 2020. In this last post of the year, we bring you articles from our blog that cover the major advances in the gut microbiome in 2020, from bench to bedside.
by GMFH Editing Team
Host lifestyle and diet are known to have a significant impact on the gut microbiome. A large observational study across 3400 individuals shows that, beyond interindividual variability, gut microbiome heterogeneity may play a role in individual responses to diet, lifestyle and medication.
by Andreu Prados
A new study of 6,811 subjects from the American Gut Project, led by Rob Knight explores in depth how fermented foods impact gut microbiota composition and function.
by Andreu Prados
The microbiota of infants born by caesarean section resembles that of maternal oral cavity and skin, whereas that of vaginally born infants resembles that of the maternal gut microbiome. A new proof-of-concept study shows that the gut microbiota of C-section-born infants can be restored after delivery via orally administered maternal fecal microbiota transplantation.
by GMFH Editing Team
The heterogeneity of cross-sectional IBS studies has limited elucidating the gut ecosystem’s overall involvement in the disease pathogenesis. New longitudinal research that integrates multi-omics, patient and gastrointestinal data reveals previously unidentified targets that accompany changes in IBS activity.
by Andreu Prados
An altered balance of the community of microbes that reside in our body, especially within the gut, has been linked to a wide range of intestinal and extraintestinal diseases. What evidence-based strategies are currently available for modulating the gut microbiota?
by GMFH Editing Team
Undernutrition still remains a major cause of death in children in some locations. A team led by Tahmeed Ahmed and Jeffrey I. Gordon have found a new driver for stunting: the bacteria that reside within the small intestine.
Diet is one of the cornerstones for managing IBS. The study of mechanisms of action coupled with symptom-related data are valuable for understanding the role of exclusion diets in patients with IBS.
